Opus Genetics (IRD) Non Operating Income (2010 - 2020)
Opus Genetics' (IRD) quarterly Non Operating Income came in at $102411.0 in Q3 2020, down 68.14% year-on-year from $321394.0 in Q4 2019, and up 162.96% on a QoQ basis from -$162660.0 in Q2 2020.
Opus Genetics (IRD) Non Operating Income (2010 - 2020) Analysis & Trends
Opus Genetics (IRD) has 11 years of Non Operating Income data on file, last reported at $102411.0 in Q3 2020.
- On a quarterly basis, Non Operating Income fell 68.14% year-over-year to $102411.0 in Q3 2020; TTM through Sep 2020 was $55063.0, a 98.72% decrease from a year earlier, with the FY2019 full-year figure at $2.6 million, down 58.19% from the prior year.
- Non Operating Income for Q3 2020 stood at $102411.0, up from -$162660.0 in the prior quarter.
- Over the last five years, Non Operating Income for IRD reached as high as $5.2 million in Q2 2017 and fell as low as -$17.7 million in Q1 2017.
- Historically, Non Operating Income has averaged $412144.4 across 5 years, with a median of $850579.0 in 2016.
- Across the five-year window, Non Operating Income jumped 389.69% in 2016 and plunged 2569.83% in 2017, its largest moves.
- Year by year, Non Operating Income stood at $3.4 million in 2016, then slumped by 61.52% to $1.3 million in 2017, then surged by 41.67% to $1.8 million in 2018, then tumbled by 92.47% to $139286.0 in 2019, then retreated by 26.47% to $102411.0 in 2020.
- Per Business Quant data, the three most recent Non Operating Income figures were $102411.0 in Q3 2020, -$162660.0 in Q2 2020, and -$23974.0 in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -8.59 Mn |
| 10 | Opus Genetics | 263.72 Mn | 203.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 102,411.00 |
| Jun 30, 2020 | -162,660.00 |
| Mar 31, 2020 | -23,974.00 |
| Dec 31, 2019 | 139,286.00 |
| Sep 30, 2019 | 321,394.00 |
| Jun 30, 2019 | 524,133.00 |
| Mar 31, 2019 | 1.59 Mn |
| Dec 31, 2018 | 1.85 Mn |
| Sep 30, 2018 | -654,912.00 |
| Jun 30, 2018 | 1.16 Mn |
| Mar 31, 2018 | 3.81 Mn |
| Dec 31, 2017 | 1.31 Mn |
| Sep 30, 2017 | 3.18 Mn |
| Jun 30, 2017 | 5.23 Mn |
| Mar 31, 2017 | -17.66 Mn |
| Dec 31, 2016 | 3.39 Mn |
| Sep 30, 2016 | 850,579.00 |
| Jun 30, 2016 | 2.15 Mn |
| Mar 31, 2016 | 714,939.00 |
| Dec 31, 2015 | 1.52 Mn |